Took a look at Polymedics. They have two products of their own, Suprathel and Supra SDRM along with a production facility, offices in Germany and Atlanta. They have distribution agreements with Polynova for Novosorb and with Vericel for Nexobrid. Along with Recell they will be representing four companies with five non-competing products. Each product is used in different phases or aspects of burn treatment. Since there really aren't any major pharmas in the burn space makes sense I suppose to partner with a distribution network that's in a niche market. All five products have approvals from FDA and I believe BARDA also.
AVH Price at posting:
$3.95 Sentiment: Hold Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)